Progyny, Inc. (NASDAQ:PGNY – Get Rating) Chairman David J. Schlanger sold 41,667 shares of the firm's stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $41.65, for a total transaction of $1,735,430.55. Following the completion of the transaction, the chairman now directly owns 82,548 shares of the company's stock, valued at approximately $3,438,124.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Progyny Stock Performance
NASDAQ PGNY opened at $45.01 on Friday. The firm has a 50 day simple moving average of $31.47 and a 200-day simple moving average of $37.53. Progyny, Inc. has a one year low of $25.67 and a one year high of $68.32. The firm has a market cap of $4.14 billion, a price-to-earnings ratio of 97.85, a PEG ratio of 12.29 and a beta of 1.85.
Get
Progyny alerts:
Progyny (NASDAQ:PGNY – Get Rating) last posted its quarterly earnings data on Thursday, August 4th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.05 by $0.04. Progyny had a net margin of 7.39% and a return on equity of 17.11%. The business had revenue of $195.00 million during the quarter, compared to analyst estimates of $190.51 million. During the same quarter last year, the firm posted $0.19 earnings per share. The business's revenue for the quarter was up 51.5% compared to the same quarter last year. Equities analysts predict that Progyny, Inc. will post 0.17 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC purchased a new position in Progyny in the second quarter worth approximately $3,103,000. American International Group Inc. lifted its stake in Progyny by 1.4% in the second quarter. American International Group Inc. now owns 151,247 shares of the company's stock worth $4,394,000 after acquiring an additional 2,020 shares during the last quarter. Natixis purchased a new position in Progyny in the second quarter worth approximately $587,000. Northern Trust Corp lifted its stake in Progyny by 4.6% in the second quarter. Northern Trust Corp now owns 1,011,596 shares of the company's stock worth $29,388,000 after acquiring an additional 44,722 shares during the last quarter. Finally, AWM Investment Company Inc. purchased a new position in Progyny in the second quarter worth approximately $871,000. Hedge funds and other institutional investors own 82.51% of the company's stock.
Progyny Company Profile
(Get Rating)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Read More
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
